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Abstract
The existence of beta-amyloid [Ab] peptides in the brain has been regarded as the most archetypal biomarker of
Alzheimer’s disease [AD]. Recently, an early clinical diagnosis has been considered a great importance in identifying
people who are at high risk of AD. However, no microscale electronic sensing devices for the detection of Ab
peptides have been developed yet. In this study, we propose an effective method to evaluate a small quantity of
Ab peptides labeled with fluorescein isothiocyanate [FITC] using a photosensitive field-effect transistor [p-FET] with
an on-chip single-layer optical filter. To accurately evaluate the quantity of Ab peptides within the cells cultured on
the p-FET device, we measured the photocurrents which resulted from the FITC-conjugated Ab peptides expressed
from the cells and measured the number of photons of the fluorochrome in the cells using a photomultiplier tube.
Thus, we evaluated the correlation between the generated photocurrents and the number of emitted photons. We
also evaluated the correlation between the number of emitted photons and the amount of FITC by measuring the
FITC volume using AFM. Finally, we estimated the quantity of Ab peptides of the cells placed on the p-FET sensing
area on the basis of the binding ratio between FITC molecules and Ab peptides.
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Introduction
Since the discovery of Alzheimer’s disease [AD] in 1906,
numerous AD researches have grown intensively from
many angles during the past several decades [1-4].
Recently, the importance of early clinical diagnosis has
been recognized to diagnose people at high risk of AD.
According to the established hypotheses on AD during
the past decade, the extracellular deposits of beta-amy-
loid [Ab] peptides forming plaques and the intracellular
neurofibrillary tangles have been regarded as the major
histopathological hallmarks of AD [5-10]. Biologically,
more evolved studies examined that Ab peptides which
are incorporated into planar lipid bilayers of neurons
induce multimeric ion channels inducing excessive cal-
cium influx into neurons and subsequent neuritic
degeneration and death [11]. Another hypothesis sug-
gested that soluble Ab oligomers are the origin of neu-
rotoxicity before Ab aggregation process proceeds
further and forms plaques [12].
As an Ab detection tool, highly sophisticated neuroi-
maging techniques have been developed such as single
photon emission computed tomography [13] and posi-
tron-emission tomography [14]. However, the neuroima-
ging systems have rather limitations in spatial resolution
for the identification of nanoscale Ab with a molecular-
level precision because their detection depends on the
computed images of Ab plaque clumps. Recently, with
rapid development of microtechnology, the incorpora-
tion of microfabricated devices with biochemical analysis
techniques has been dramatically increased. Antibody-
conjugated microbead arrays on a substrate were used
for a multiplexed detection of several types of proteins
in a microelectrophoretic device, which was, however,
also on the basis of a fluorescence imaging technique
[15]. Surface-enhanced Raman scattering spectroscopy
was utilized to detect biomolecules in a label-free way
when electrokinetically preconcentrated to amplify the
low concentrations, which is also difficult for accurate
quantification.
As a result of the recent AD researches, the in vivo
physiological quantity of Ab peptides has been known
to be a few nanomoles in concentration. Therefore, the
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fication of a small amount of Ab peptides ranging from
a few femtomoles to nanomoles is required. These chal-
lenging biosensors with the capability of Ab peptide
quantification at a low concentration have not been
developed yet for early AD diagnosis. Thus, this study
suggests a new approach capable of evaluating a small
quantity of Ab peptide using a simple, thin-film field-
effect transistor and shows the results of the photocur-
rents resulted from a fluorescence signal.
Methods
Photosensitive field-effect transistor
As shown in Figure 1, we propose an effective method
to measure the quantity of Ab peptides labeled with
fluorescein isothiocyanate [FITC] using a photosensitive
field-effect transistor [p-FET] with an on-chip single-
layer optical filter. The in vitro microsystem mainly con-
sists of an upper biofluidic part where the cultured cells
are introduced on top of the optical filter through a
polydimethylsiloxane [PDMS] channel and an
underlying thin film p-FET as the signal transducer part
which was fabricated with an optically high-efficient
amorphous Si [a-Si] layer on a Si/SiO2 substrate. A dro-
plet including cells with intra/extracellular Ab peptides
is placed on the laminin-coated sensing area of the p-
FET device, which is, after overnight incubation at 37°C,
followed by the treatment of both the primary antibody
for Ab peptides and secondary antibody conjugated with
fluorochrome.
Mathematical approach
In Figure 1, the fluorochrome molecules bound to the
Ab peptides are excited by blue laser irradiation (lex)a t
ah i g he n e r g yl e v e la n de m i tv isible fluorescent light
(lem) at a low energy level. Through this process, the fil-
ter surface unoccupied by the cells reflects the
unwanted range of blue laser irradiation and only trans-
mits the fluorescently emitted light through the filter.
When the fluorescent light (dotted red line) emitted by
the excitation (dotted blue line) is transmitted through
the optical filter and approaches the p-FET sensing area
Figure 1 Conceptual illustration of a p-FET. The p-FET is integrated with an on-chip optical filter composed of a selectively transmissible
material at a particular wavelength to evaluate a small quantity of Ab peptides conjugated with FITC. The unwanted range of excitation light
(lex) is reflected, and only the fluorescent light emitted at a proper wavelength (lem) is transmitted through the filter and converted to the
electrical signal. The inset shows the actual p-FET device.
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Page 2 of 6(i.e., a-Si surface), excess charge carriers are generated
by the absorbed photons within the a-Si sensing layer
to give rise to a measurable photocurrent, which can be
theoretically expressed as follows:
Ip =
 e
hv

(1 − R)η

1 − e−αvd

PFET =
 e
hv

CFETPFET, (1)
where Ip is the photocurrent generated by p-FET, e is
the electron charge, h is the Planck constant, and ν is
the photon frequency of fluorescence emission. The
remaining parts of Equation 1 represent the optical
properties related to the p-FET device which can be
designated as a single constant, CFET, R is the reflec-
tance, h is the quantum efficiency, a is the absorption
coefficient of the photon, and d is the p-FET sensing
layer thickness. Therefore, Ip is directly proportionate to
PFET which represents the intensity of the incident fluor-
escent light transmitted through the filter. Also, the
intensity of the fluorescent transmittance onto the p-
FET is linearly proportional to the multiplication of the
intensity of emitted fluorescence (Pem) from fluoro-
chrome before transmission and the transmittance coef-
ficient (T) of the optical filter for the emitted
wavelength:
PFET = TP em. (2)
Meanwhile, Pem definitely relies on the number of the
emitted photons from the fluorochrome excited by the
blue laser. By the definition of the quantum yield as fol-
lows:
  ≡
# of emitted photons
# of absorbed photons
, (3)
the number of emitted photons indicates the multipli-
cation of the quantum yield and the number of photons
absorbed within the fluorochrome. Subsequently, Pem
can be mathematically expressed as follows:
Pem =   × (# of absorbed photons) =  

1 − e−Aλ
, (4)
where Al is the absorbance of fluorochrome for the
specified wavelength which is defined as the logarithmic
value of the ratio of the intensity of light passed through
fluorochrome to the intensity of incident light. There-
fore, Equation 1 can be completely rewritten as follows:
Ip =
 e
hν

CFETT 

1 − e−Aλ
= C

1 − e−Aλ
, (5)
where C represents an arbitrary constant. Since the
absorbance, Al, is proportionate to the volume (or mass,
or thickness) and the concentration of the absorbing
species, Equation 5 meaningfully indicates that high
electrical current may be generated by the p-FET device
for a large amount of the Ab-conjugated fluorochrome
and vice versa. Eventually, since the quantity of Ab pep-
tides is directly proportionate to that of the tagged
fluorochrome, the photocurrents generated by p-FET
are a function of the amount of Ab peptides specifically
conjugated with fluorochrome.
Even though the exact relationship would not be avail-
able in a form of an equation in this study, the photo-
current generated by the p-FET device would be
expressed as a linear function of the amount of the Ab-
conjugated fluorochrome and potentially provide the
quantified Ab concentration.
Results and discussion
Fluorochrome-conjugated Ab expressed on a cell line
We prepared a circular PDMS well with a diameter of
200 μm to guide the biological sample solution. It was
aligned on the p-FET surface, so the sensing area was
placed in the middle of the well as shown in Figure 2a.
After washing three times with phosphate-buffered sal-
ine, laminin as an extracellular matrix was coated on
the channel, and the channel was kept overnight in an
incubator at 37°C.
We prepared HeLa cells for the expression of Ab pep-
tides. The HeLa cells (density 10
4/μl) were brought to
the p-FET surface and cultured overnight in the incuba-
tor for stabilization as shown in Figure 2b. Thereafter,
the HeLa cells were fixed with 4% paraformaldehyde for
1 h at room temperature, and then, the blocking with
4% bovine serum albumin was carried out for 1 h to
protect nonspecific antibody bindings in the next step.
Then, the overnight incubation with a primary antibody
(Abcam, Cambridge, MA, USA) was performed for the
specific binding to Ab peptides on the HeLa cells.
The subsequent treatment with a secondary antibody
(Invitrogen, Carlsbad, CA, USA) tagged with FITC was
performed for 1 h (Figure 2c). The synthetic ratio of
Ab to FITC is defined to be 1:4 by the manufacturer
(USBiological, Swampscott, MA, USA). After the fluor-
escence treatment with FITC, the nuclei of the HeLa
cells were stained using 4’,6-diamidino-2-phenylindole
[DAPI] (Figure 2d), and the p-FET sensor was imaged
using a fluorescent microscope and was irradiated by a
405-nm blue laser as an excitation source for FITC to
measure the photocurrent. The reason that we used
the 405-nm blue laser was attributed to the intention
of forming a thin, single-layer filter on the p-FET sur-
face, not using multilayer, commercial optical filters.
We developed a thermally evaporated thin arsenic tri-
sulfide (As2S3) filter which almost blocks the lights
below 450 nm and transmits longer than approxi-
mately 500 nm. Figure 2e, f shows the typical
morphologies of HeLa cells cultured on a flat PDMS
surface.
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Page 3 of 6Figure 2 Cell culture and visualization on the p-FET device.( a) A microscopic optical image of the p-FET sensing areas placed in the middle
of the PDMS well. (b) The HeLa cells were brought to the p-FET surface and cultured overnight in the incubator for stabilization. (c) The HeLa
cells were visualized with FITC specifically bound to the Ab peptides expressed on the cell surface. (d) The nuclei of the HeLa cells stained using
DAPI. (e, f) The HeLa cells cultured on a flat PDMS surface were visualized with FITC and DAPI, respectively.
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We investigated the applicability of our p-FET sensor to
the actual detection of Ab peptides existing in the HeLa
cells. In Figure 3a, approximately 13 HeLa cells placed
on the p-FET sensing area in the middle of a PDMS cir-
cular well were visualized with FITC specifically bound
to the Ab peptides expressed on the cell membranes.
The peptides rather feebly fluoresced when stimulated
by a blue excitation laser at a 405-nm wavelength. The
photocurrents generated by the fluorescence emitted
from the FITC-conjugated Ab peptides were measured
as shown in Figure 3b. Only with the optical filter layer
on the p-FET (without any cells), approximately 5 nA of
photocurrents (black line) were generated when the p-
FET device was irradiated by the blue laser during the
shutter-on (5.5 to 10.5 s), indicating that most of the
excitation light was reflected by the filter layer. How-
ever, with the FITC-labeled cells on the optical filter
layer, the photocurrents measured approximately 350
nA with 220-nA increments, assuming that the photo-
current generated by a single cell roughly corresponds
to approximately 18 nA. Therefore, it is expected that
our p-FET sensor can be used as a detector for low-
level Ab peptides with weak fluorescence emission.
Figure 3c shows the FITC-stained HeLa cells with bet-
ter cellular shapes on a flat PDMS surface. To evaluate
the correlation between the generated photocurrent and
the number of emitted photons from a single cell, we
Figure 3 Quantitative analysis of FITC.( a) Thirteen HeLa cells placed on the p-FET sensing area in the middle of the PDMS circular well were
visualized with FITC bound to the Ab peptides expressed on the cell membranes. (b) The photocurrents generated by the fluorescence emitted
from the FITC-conjugated Ab peptides were measured. (c) The number of photons of the single cell in the yellow dotted circle was measured
using a PMT. (d) Calibration data of the photon counting as a linear function of the FITC volume.
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the yellow dotted circle using a photomultiplier tube
[PMT]. As a result of the PMT measurement, a single
fluorescent cell emitted approximately 1.3 × 10
6 photons
in 1 s, which corresponds to 17 nA of photocurrent
when compared to the p-FET measurement.
To accurately evaluate the quantity of Ab peptides
within a single cell as the ultimate purpose of this study,
the information on how many FITC molecules exist
within a single cell is imperatively required. Therefore,
a ss h o w ni nE q u a t i o n4 ,t h eq u a n t u my i e l df o rF I T C
molecules experimentally measured 0.12, which was
excited at 405 nm and emitted at 510 nm. According to
both the measured quantum yield for our system and
the PMT result for the photon number within a single
cell (approximately 1.3 × 10
6 photons), the concentra-
tion of FITC molecules existing within a single cell was
roughly evaluated to be approximately 10 fM. After all,
the photocurrent of 220 nA measured by p-FET for 13
HeLa cells represents approximately 130 fM of FITC
molecules, and the concentration of Ab peptides is eval-
u a t e dt ob e4 0t o5 0f Mo nt h eb a s i so ft h em a n u f a c -
turer synthesis ratio (4:1) between FITC and Ab.F i g u r e
3d represents the calibration data of the photon count-
ing using PMT measurement, showing a linear function
of the FITC volume.
Conclusions
We proposed an effective method to measure the quan-
tity of Ab peptides labeled with FITC using a p-FET
with an on-chip single-layer optical filter. To accurately
evaluate the quantity of Ab peptides within the cells cul-
tured on the p-FET device, we measured the photocur-
rents which resulted from the FITC-conjugated Ab
peptides expressed from the cells and measured the
number of photons of the fluorochrome in the cells
using a PMT. Thus, we evaluated the correlation
between the generated photocurrents and the number of
emitted photons. We also evaluated the correlation
between the number of emitted photons and the
amount of FITC by measuring the FITC volume using
AFM. Finally, we estimated the quantity of Ab peptides
of the cells placed on the p-FET sensing area on the
basis of the binding ratio between FITC molecules and
Ab peptides.
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